40
Participants
Start Date
February 3, 2021
Primary Completion Date
December 28, 2023
Study Completion Date
December 28, 2023
Transcranial magnetic stimulation
Transcranial magnetic stimulation (TMS) is a noninvasive FDA-approved technique that is commonly used as a treatment for depression. It has been shown to focally activate specific brain regions that are believed to be underactive in patients suffering from depression. In this study, TMS will be administered within FDA-approved guidelines under the supervision of a physician with experience in administering the treatment and monitoring for complications.
Brigham & Women's Hospital, Boston
Brigham and Women's Hospital
OTHER